PT1485084E - Utilizacao de um sal de acido l-ascorbico para a preparacao de uma composicao farmaceutica para a utilizacao topica oftalmologica capaz de melhorar o nivel de acido l-ascorbico no olho - Google Patents
Utilizacao de um sal de acido l-ascorbico para a preparacao de uma composicao farmaceutica para a utilizacao topica oftalmologica capaz de melhorar o nivel de acido l-ascorbico no olhoInfo
- Publication number
- PT1485084E PT1485084E PT03744341T PT03744341T PT1485084E PT 1485084 E PT1485084 E PT 1485084E PT 03744341 T PT03744341 T PT 03744341T PT 03744341 T PT03744341 T PT 03744341T PT 1485084 E PT1485084 E PT 1485084E
- Authority
- PT
- Portugal
- Prior art keywords
- ascorbic acid
- eye
- improving
- preparation
- level
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002MI000557A ITMI20020557A1 (it) | 2002-03-15 | 2002-03-15 | Uso di un sale dell'acido l-ascorbico per preparare una composizione farmaceutica per uso topico oftalmico capace di migliorare il livello d |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1485084E true PT1485084E (pt) | 2006-08-31 |
Family
ID=11449521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT03744341T PT1485084E (pt) | 2002-03-15 | 2003-03-05 | Utilizacao de um sal de acido l-ascorbico para a preparacao de uma composicao farmaceutica para a utilizacao topica oftalmologica capaz de melhorar o nivel de acido l-ascorbico no olho |
Country Status (12)
Country | Link |
---|---|
US (1) | US20060004089A1 (pt) |
EP (1) | EP1485084B9 (pt) |
AR (1) | AR039604A1 (pt) |
AT (1) | ATE322262T1 (pt) |
AU (1) | AU2003210419A1 (pt) |
CA (1) | CA2476908A1 (pt) |
DE (1) | DE60304458T2 (pt) |
DK (1) | DK1485084T3 (pt) |
ES (1) | ES2260634T3 (pt) |
IT (1) | ITMI20020557A1 (pt) |
PT (1) | PT1485084E (pt) |
WO (1) | WO2003077905A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008002582A2 (en) * | 2006-06-27 | 2008-01-03 | Riolan Technologies, Inc. | Ultraviolet absorbing ophthalmic compositions |
US10220012B2 (en) * | 2016-06-03 | 2019-03-05 | Joerg H. KRUMEICH | Solution for ophthalmology |
US20210128526A1 (en) * | 2019-11-05 | 2021-05-06 | Rajiv R. Mohan | Eye drops to treat chemically induced corneal damage |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4490389A (en) * | 1976-03-11 | 1984-12-25 | Nelson Research & Development Co. | Contact lens preserving solution containing ascorbic acid or salts thereof |
JPS5821614A (ja) * | 1981-07-31 | 1983-02-08 | Ss Pharmaceut Co Ltd | 点眼剤 |
DE3133003A1 (de) * | 1981-08-20 | 1983-03-10 | Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri | Mittel zur behandlung von truebungen im bereich des auges |
US4886815A (en) * | 1984-06-20 | 1989-12-12 | Schachar Ronald A | Treatment and prevention of retinal edema with dopaminergic antagonists |
US4620979A (en) * | 1985-08-02 | 1986-11-04 | Schachar Ronald A | Ophthalmological irrigating solution containing ascorbate |
DE3838431A1 (de) * | 1988-11-12 | 1990-05-17 | Bayer Ag | Ibuprofen-brausezubereitungen |
US5523316A (en) * | 1994-06-23 | 1996-06-04 | Alcon Laboratories, Inc. | Intraocular irrigating solution containing agent for controlling IOP |
IT1277707B1 (it) * | 1995-12-22 | 1997-11-11 | Chemedica Sa | Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare |
US5817630A (en) * | 1997-03-18 | 1998-10-06 | Austin Nutriceutical Corporation | Glutathione antioxidant eye drops |
DE19729879C2 (de) * | 1997-07-11 | 1999-07-08 | Mann Gerhard Chem Pharm Fab | Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin |
WO2002001954A1 (en) * | 2000-07-05 | 2002-01-10 | The Board Of Trustees Of The University Of Arkansas | Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury |
-
2002
- 2002-03-15 IT IT2002MI000557A patent/ITMI20020557A1/it unknown
-
2003
- 2003-03-05 WO PCT/EP2003/002258 patent/WO2003077905A1/en not_active Application Discontinuation
- 2003-03-05 ES ES03744341T patent/ES2260634T3/es not_active Expired - Lifetime
- 2003-03-05 PT PT03744341T patent/PT1485084E/pt unknown
- 2003-03-05 EP EP03744341A patent/EP1485084B9/en not_active Expired - Lifetime
- 2003-03-05 AT AT03744341T patent/ATE322262T1/de not_active IP Right Cessation
- 2003-03-05 DK DK03744341T patent/DK1485084T3/da active
- 2003-03-05 CA CA002476908A patent/CA2476908A1/en not_active Abandoned
- 2003-03-05 AU AU2003210419A patent/AU2003210419A1/en not_active Abandoned
- 2003-03-05 US US10/507,025 patent/US20060004089A1/en not_active Abandoned
- 2003-03-05 DE DE60304458T patent/DE60304458T2/de not_active Expired - Fee Related
- 2003-03-14 AR ARP030100891A patent/AR039604A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1485084B1 (en) | 2006-04-05 |
DE60304458D1 (de) | 2006-05-18 |
ITMI20020557A0 (it) | 2002-03-15 |
AR039604A1 (es) | 2005-03-02 |
EP1485084A1 (en) | 2004-12-15 |
EP1485084B9 (en) | 2006-08-23 |
DK1485084T3 (da) | 2006-07-31 |
ATE322262T1 (de) | 2006-04-15 |
ITMI20020557A1 (it) | 2003-09-15 |
DE60304458T2 (de) | 2006-10-12 |
US20060004089A1 (en) | 2006-01-05 |
ES2260634T3 (es) | 2006-11-01 |
CA2476908A1 (en) | 2003-09-25 |
WO2003077905A1 (en) | 2003-09-25 |
AU2003210419A1 (en) | 2003-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0514735B8 (pt) | derivados de pirimidino sulfonamida como moduladores do receptor de quimiocina. | |
BRPI1006115A8 (pt) | "agentes indutores de apoptose para o tratamento de câncer e doenças autoimunes". | |
CL2003002683A1 (es) | Enantiomeros s de compuestos derivados del acido (2s)-3-4(-{2-amino-2-oxoetoxi}fenil)-2-etoxipropanoico; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento o prevencion de trastornos de lipidos, | |
EP1598371A4 (en) | THERAPEUTIC COMPOSITION FOR OPHTHALMIC USE CONTAINING ACETYL HYALURONIC ACID | |
EA202091303A3 (ru) | Композиция ингибитора jak для местного применения | |
WO2004072085A3 (de) | Salz einer sulfonsäure mit clopidogrel und dessen verwendung zur herstellung pharmazeutischer formulierungen | |
EP2650293A8 (en) | [1,2,4]triazolo[4,3-b][1,2,4]triazine compound, preparation method and use thereof | |
BRPI0518993A2 (pt) | composto ou um sal, solvato ou Éster farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, e, uso de um composto | |
BRPI0606606A2 (pt) | composições estáveis contendo prostaglandina | |
TW200606164A (en) | New compounds | |
IL198180A (en) | Salt p- toluene 5-amino-3-sulfonic acid (2'-0-acetyl-3'-deoxy-ß-d-riboforanosyl) -3h-thiazole [5,4- d] pyrimidine-2-on crystalline form , A pharmaceutical product containing it, its use in the preparation of a drug and methods for its manufacture | |
RS54050B1 (en) | FORMULATIONS AND METHODS FOR THE TREATMENT OF AMYLOIDOSIS | |
TW200800984A (en) | New compounds | |
AR029412A1 (es) | Forma cristalina | |
BRPI0017528B8 (pt) | uso de uma composição contendo sal de cetotifeno | |
NO20092764L (no) | Isosorbid mononitrat derivater for behandling av okular hypertensjon | |
PT1485084E (pt) | Utilizacao de um sal de acido l-ascorbico para a preparacao de uma composicao farmaceutica para a utilizacao topica oftalmologica capaz de melhorar o nivel de acido l-ascorbico no olho | |
WO2005070903A3 (en) | Sulphonamide substituted triazines as chemokine receptor modulators | |
EP2722322B8 (en) | 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient | |
ATE385786T1 (de) | Pharmazeutische zusammensetzung in form eines hydrogels zur transdermalen verabreichung von wirkstoffen | |
BRPI0720089A2 (pt) | Uso de l-carnitina para a preparação de um medicamento na forma de colírio para o tratamento de doenças da córnea | |
IL182835A0 (en) | Process for and imtermediates in the preparaition of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents | |
BRPI0115076B8 (pt) | preparação farmacêutica, sua aplicação farmacêutica, bem como processo para preparação da mesma | |
SI1485084T1 (sl) | Uporaba soli L-asklorbinske kisline za pripravo farmacevtskega sestavka za oftalmicno topikalno uporabo, ki ima sposobnost izboljsati nivo L-askorbinske kisline v ocesu | |
BRPI0412453A (pt) | uso do ácido ascórbico ou um sal fisiologicamente aceitável do mesmo |